Drug Topics

JULY 7, 2025

image credit: Drobot Dean / stock.adobe.com READ MORE: ACIP Votes to Expand RSV Vaccine Recommendation to Include Adults 50 Years and Older Along with older adults over 65, children too are deemed at risk of contracting respiratory illnesses; a risk that was significantly increased during the COVID-19 pandemic.

Independent Pharmacies

Pharmaceutical Technology

JUNE 18, 2025

The vaccine specialist stated its EBITDA will be positively impacted, with an update occurring when the transaction closes. Bavarian Nordic won its PRV when its chikungunya vaccine Vimkunya was approved by the FDA in February 2025. Vimkunya is the second approved chikungunya vaccine in the US, with Valneva’s Ixchiq also at the market.

FDA

STAT

MARCH 3, 2025

Even more, there is a highly effective vaccine against HPV, the virus that causes most cervical cancer diagnoses. The cross-sectional study found incidence and mortality rates have been climbing in rural counties in the United States since 2012, going in the wrong direction after declining since 2001.   Read the rest…

Vaccines

European Pharmaceutical Review

DECEMBER 23, 2024

November 2012. Internet] Vaccines Europe. EMA/CHMP/ICH/214732/2007. ICH Q11 Development And Manufacture Of Drug Substances (Chemical Entities And Biotechnological/Biological Entities) – Scientific Guideline. EMA/CHMP/ICH/425213/2011. 4 March 2020. EMA/CHMP/ICH/804273/2017. J Pharm Sci. 2024; 113: 837-855. Final concept Paper.

Vaccines

European Pharmaceutical Review

OCTOBER 10, 2022

The US Food and Drug Administration (FDA) has approved GlaxoSmithKline Biologicals’ Boostrix vaccine for use in pregnant woman in their third trimester, to prevent against whooping cough (pertussis) in infants up to two months of age. Since 2012, the CDC has recommended the vaccine series during the third trimester of each pregnancy.

Vaccines

Pharmaceutical Technology

OCTOBER 10, 2022

The US Food and Drug Administration (FDA) has approved GlaxoSmithKline ’s (GSK) Boostrix (tetanus toxoid, reduced diphtheria toxoid, and acellular pertussis vaccine adsorbed [Tdap]) for pregnant women during their third trimester to prevent pertussis (whooping cough) in newborn infants.

Vaccines

Hospital Pharmacy Europe

OCTOBER 14, 2024

The idea of cancer vaccines is not new, but Dr Victoria Kunene, consultant medical oncologist at Queen Elizabeth Hospital Birmingham, UK, is leading the charge in their latest iteration: personalised preventative and therapeutic mRNA vaccines against colorectal cancer.

Vaccines

European Pharmaceutical Review

DECEMBER 19, 2023

Many of today’s vaccines are produced in ready-to-inject liquid formulations that must be kept cold to maintain stability. However, this greatly complicates both the worldwide distribution and stockpiling of vaccines and other drugs. A requisite cold chain has been designed and implemented to be uninterrupted from factory to patient.

Vaccines

European Pharmaceutical Review

JULY 20, 2022

Our research looked at products that were voluntarily withdrawn, or had their licence revoked or suspended within the EU for a safety reason between 2012 and 2016. Researchers also study the long-term effects of medicines and vaccines, as well as the safety of new and advanced products. Study focus. almitrine – a respiratory stimulant.

Adverse Reactions

pharmaphorum

FEBRUARY 3, 2021

billion in 2018, according to the latest BioIndustry Association (BIA) and Clarivate report, and represents a 1,000% increase on 2012. That makes 2020 a new record year for the sector, exceeding the previous investment high of £2.2

Vaccines

ISPE

OCTOBER 25, 2022

Throughout her early career, she successfully led multiple biotech, vaccine, and API processes from late-stage research and development to clinical and commercial manufacturing. She also worked on design and CQV projects of all sizes and provided business solutions to spearhead expansion of NNE and ADVENT.

Vaccines

European Pharmaceutical Review

FEBRUARY 27, 2024

In 2012, Dame June was elected as the first chair of the European Pharmacovigilance Risk Assessment Committee, MHRA added. While she is stepping down from her current role, Dame June shared that she still hopes to contribute “to patient safety and public health in other ways.”

Communication

Hospital Pharmacy Europe

MARCH 13, 2025

The Government said the move would reduce complex bureaucracy and undo the damage caused by 2012 reorganisation, led by then-health secretary Andrew Lansley and which saw the formation of NHS England as an arms-length body in 2013. When money is so tight, we cant justify such a complex bureaucracy with two organisations doing the same jobs.

Community Pharmacies

pharmaphorum

JANUARY 5, 2023

It’s also an industry where technologists have recently made massive contributions, whether it’s getting COVID vaccines to market faster or making unprecedented advancements in predictive AI, like Chroma from Generate Biomedicines. Since co-founding Benchling in 2012, Ashu has overseen the company’s rapid growth. About the author.

Hospitals

pharmaphorum

OCTOBER 12, 2022

Del Bourgo highlights that genomic treatments work in a similar way to mRNA, which has been used in COVID-19 vaccines. Just as mRNA and COVID-19 showed the world that it’s possible to develop vaccines much faster, Del Bourgo explains, AI can help us develop new genomic medicines in a more efficient way.

Immunization

pharmaphorum

SEPTEMBER 18, 2020

In June 2007, AstraZeneca completed the acquisition of vaccine maker MedImmune, buying its drug-development pipeline for $15.2 AstraZeneca was one of the top ten pharmaceutical companies in the world in 2012, but faced a string of patent expiries in its blockbuster drugs. Blockbusters go off patent. Pascal Soriot. A comeback story?

Pharmaceutical Companies

ISPE

OCTOBER 28, 2022

Dr Gouws added that WHO was the only regulatory authority to have performed inspections of Chinese manufacturers of Covid-19 vaccines during the pandemic. Dr Gouws indicated that many of the Covid-19 vaccine manufacturers in India had also been inspected by WHO and a similar information sharing approach had been undertaken by WHO.

FDA

Pharmaceutical Technology

MAY 26, 2023

While the market was worth over $6 billion in 2012, this has now grown to nearly $48 billion only a decade later, said Avigayil Chalk, PhD, GlobalData’s Senior Oncology and Haematology analyst, at an immuno-oncology webinar held on May 23. Checkpoint modulators are forecasted to retain the largest share of this, based on the webinar.

Immunization

pharmaphorum

JANUARY 19, 2023

He continued: “I think this is largely because, since 2012, the budget has been hugely skewed towards acute services […] Successive governments have raided the budget of the healthcare system. The vaccine programme is the best example,” Lord Prior said. The NHS is clearly a failing system.

Hospitals

European Pharmaceutical Review

FEBRUARY 3, 2023

percent in 2012 to 3.2 This historically saw an average clawback rate of seven percent prior to the pandemic. Impact on the UK’s pharmaceutical industry The UK’s share of global pharmaceutical R&D has been declining over the past decade, falling from 4.9 percent in 2022, the industry body stated.

Vaccines

PharmaShots

MARCH 14, 2023

The act includes drugs, vaccines, and therapeutics that are intended to treat a disease affecting <200,000 American citizens. UniQure’s Glybera is the first approved gene therapy by the EMA in the year 2012 for the treatment of a rare disease lipoprotein lipase deficiency.

FDA

Hospital Pharmacy Europe

FEBRUARY 16, 2023

In fact, work from 2012 showed that the use of a TLR-2 agonist in mice offered protection against influenza. Given the important role of TLRs in the earliest phase of a host’s immune response, the development of TLR agonists is a promising therapeutic strategy.

Immunization

pharmaphorum

OCTOBER 12, 2021

Belgium-born Stoffels has been CSO at J&J since 2012, and was global head of pharma R&D for three years before that whilst also serving as chairman of the pharma division between 2011 and 2015. He has also led J&J’s venture capital arm JJDC, and made open-ended innovation and partnering a key strategy for J&J.

Vaccines

Blog: Ask a Student Pharmacist

AUGUST 23, 2023

197-217 SG Chou, AK Soper, S Khodadadi, JE Curtis, S Krueger, MT Cicerone, A Fitch, E Shalaev (2012). In : Lyophilized Biologics and Vaccines: Modality-Based Approaches. Hastedt, Eds, Drugs and the Pharmaceutical Sciences (2008), 175 (Protein Formulation and Delivery (2nd Edition)), pp.

Dosage

Pharmaceutical Technology

APRIL 20, 2023

1] Making the transition The number of decentralised clinical trials has steadily increased over the past decade, rising from 250 in 2012 to 1,291 in 2021. They are expected to peak even higher in 2022, with GlobalData forecasting the industry to hold approximately 1,425 DCTs by the end of the year. [2]

Vaccines

ISPE

SEPTEMBER 22, 2022

Paul Jansen from the company hosting the event in Boxmeer (MSD Animal Health) described the modular construction of an animal vaccine plant and shared opportunities and lessons learned. The ISPE Project Management CoP Benelux was founded in 2012. This event was sponsored by: Advirpo. Flow Technology.

Vaccines

ISPE

NOVEMBER 21, 2022

Dr Gouws added that WHO was the only regulatory authority to have performed inspections of Chinese manufacturers of Covid-19 vaccines during the pandemic. Dr Gouws indicated that many of the Covid-19 vaccine manufacturers in India had also been inspected by WHO and a similar information sharing approach had been undertaken by WHO.

FDA

PharmaShots

APRIL 25, 2023

Founded Year: 2012 Total Employees: ~190 Headquarters: California, United States Market Cap: $1.2B The company strives to discover and develop therapeutic products under its business segments, including General Medicines, Specialty Medicines, and Vaccines. Aligos is developing ALG‑125755 under its oligonucleotide platform.

HIV Treatment and Prevention Agents

Pharmaceutical Technology

JANUARY 25, 2023

7,000 more clinical trials take place each year in the Asia-Pacific region compared with 2012, and 1,200 more in the Middle East and Africa. The global vaccine rollout would never have taken place without the advances in visibility and control over supply chains that it necessitated. The world of clinical trials is changing.

Pharmaceutical Companies

Pharmaceutical Technology

JULY 23, 2008

With expensive new treatments, increasing numbers of patients in chemotherapy in major markets and developing nations like China, Brazil and Russia investing more in treating and diagnosing cancer, IMS predicts a compound growth rate of 12–15% and tips the global market to reach $80bn by 2012.

Pharmaceutical Companies

PharmaShots

APRIL 13, 2023

and became a leader in the medical device industry Novartis raised its sales by 16% and acquired Alcon (ophthalmic business), Genoptix (oncology business), and an 85% stake in Zhejiang Tianyuan (vaccine business) Bayer recorded a revenue of $49B as its pharmaceutical business posted an encouraging performance in the emerging market.

Vaccines

Pharmaceutical Technology

JANUARY 25, 2023

7,000 more clinical trials take place each year in the Asia-Pacific region compared with 2012, and 1,200 more in the Middle East and Africa. The global vaccine rollout would never have taken place without the advances in visibility and control over supply chains that it necessitated. The world of clinical trials is changing.

Pharmaceutical Companies

ISPE

AUGUST 30, 2022

During the pandemic, the pharmaceutical industry faced challenges in the production of COVID-19 therapeutics and vaccines to meet global demand, as well as mitigation of drug shortages for non-COVID-19-related products, without compromising product quality or patient safety. Published May 2012. Published 2008.

Documentation

PharmaShots

JANUARY 31, 2023

Founded Year: 2012 No. The Company's premier line of smart safety syringes, Sharps Provensa, prevents accidental needlestick injuries, prevents needle reuse, and minimizes drug and vaccine waste—all while maintaining the intuitive simplicity of conventional syringes. Funding Value: $11.4M of Shares: 1.4M Funding Value: $15.9M

Vaccines

PharmaShots

FEBRUARY 20, 2023

Medicago, has a technology called Proficia through which the company has developed Covifenz, a plant based VLP, recombinant, adjuvanted vaccine for COVID-19 in collaboration with GSK 5. Different species of Solanaceae have capacities to produce heterologous proteins such as the E.

Vaccines

European Pharmaceutical Review

DECEMBER 14, 2023

Between 1999 and 2001, it supported 17 percent of withdrawals, between 2002 and 2011, it supported 26 percent of withdrawals and by 2012 to 2016, 80 percent of withdrawals were supported by observational studies (cohort, case-control, or other epidemiologic design). Meta-analyses contributed least frequently (31.4 Lane S, Lynn E, Shakir S.

Medical Records

pharmaphorum

FEBRUARY 26, 2021

In 2012, J&J agreed to pay US $181 million to 26 states in order to settle these claims – though another lawsuit related to the drug (for $8 billion, eventually reduced to $6.8 CEO Alex Gorsky, who was appointed in 2012. Risperdal is well-known due to the controversy in the US following its product launch in 1994.

Vaccines